A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -3.54% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 15.20%. Over the past 30 days, the price of EXAS has leaped by -14.19%. And in the last five days, it has fallen by -6.23%.
Exact Sciences Corp ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $79.62 on 04/02/24, while the lowest value for the same period was recorded at $40.62 on 06/25/24.
52-week price history of EXAS Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Exact Sciences Corp’s current trading price is -31.93% away from its 52-week high, while its distance from the 52-week low is 33.42%. The stock’s price range during this period has varied between$40.62 and $79.62. The Exact Sciences Corp’s shares, which operate in the Healthcare, saw a trading volume of around 3.81 million for the day, a figure considerably higher than their average daily volume of 2.41 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Exact Sciences Corp (EXAS) has experienced a quarterly decline of -23.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 10.03B and boasts a workforce of 6600 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 62.28, with a change in price of -4.62. Similarly, Exact Sciences Corp recorded 2,407,858 in trading volume during the last 100 days, posting a change of -7.85%.
EXAS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EXAS stands at 0.87. Similarly, the long-term debt-to-equity ratio is also 0.78.
EXAS Stock Stochastic Average
Exact Sciences Corp’s raw stochastic average for the past 50 days is presently 24.91%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 8.34%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 21.58% and 22.05%, respectively.
